Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2197-2205

  Greenberg, P A ^a   Hortobagyi, G N ^a   Smith, T L ^a   Ziegler, L D ^a   Frye, D K ^a   Buzdar, A U ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BCG VACCINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; TEGAFUR; VINCRISTINE;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0029789811     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2197     Document Type: Article

References (26)

1. Cancer Facts and Figures - 1990. Atlanta, GA, American Cancer Society, 1990
2. Henderson IC, Harris JR, Kinne DW, et al: Cancer of the breast, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer - Principles & Practice of Oncology (ed 3). Philadelphia, PA, Lippincott, 1989, pp 1197-1268
3. Legha SS, Buzdar AU, Smith TL, et al: Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann Intern Med 91:847-852, 1979
4. Ross MB, Buzdar AU, Smith TL, et al: Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950's, 1960's, and 1970's. Cancer 55:341-346, 1985
5. Todd M, Shoag M, Cadman E: Survival of women with metastatic breast cancer at Yale from 1920 to 1980. J Clin Oncol 1:406-408, 1983
6. Cold S, Jensen NV, Brincker H, et al: The influence of chemotherapy on survival after recurrence in breast cancer - A population-based study of patients treated in the 1950s, 1960s and 1970s. Eur J Cancer 29A: 1146-1152, 1993
7. Paterson AHG, Szafran O, Cornish F, et al: Effect of chemotherapy on survival in metastatic breast cancer. Breast Cancer Res Treat 1:357-363, 1981
8. Powles TJ, Smith IE, Ford HT, et al: Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet i:580-582, 1980
9. Escher GC, Kaufman RJ: Advanced breast cancer - Factors influencing survival. Acta Unio Internationales Contra Cancrum 19:1039-1043, 1963
10. Vincent MD, Powles TJ, Sweet R, et al: An analysis of possible features of long-term and short-term survivors of metastatic breast cancer. Eur J Cancer Clin Oncol 22:1059-1065, 1986
11. Swenerton KD, Legha SS, Smith T, et al: Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39:1552-1562, 1979
12. Hortobagyi GN, Smith TL, Legha SS, et al: Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1:776-786, 1983
13. Hayward JL, Carbone PP, Henson JC, et al: Assessment of response to therapy in advanced breast cancer. Cancer 39:1289-1294, 1977
14. Decker DA, Ahmann DL, Bisel HF, et al: Complete responders to chemotherapy in metastatic breast cancer. JAMA 242:2075-2079, 1979
15. Pedrazzini A, Cavalli F, Brunner KW, et al: Complete remission following endocrine or combined cytotoxic and hormonal treatment in advanced breast cancer. Oncology 44:51-59, 1987
16. Bloom HJG, Richardson WW, Harries ES: Natural history of untreated breast cancer (1805-1933). Br Med J 2:213-221, 1962
17. Nash CH, Jones SE, Moon TE, et al: Prediction of outcome in metastatic breast cancer treated with Adriamycin combination chemotherapy. Cancer 46:2380-2388, 1980
18. Paterson AHG, Zuck VP, Szafran O, et al: Influence and significance of certain prognostic factors on survival in breast cancer. Eur J Cancer Clin Oncol 18:937-943, 1982
19. Cutler SJ, Asine AJ, Taylor SG III: Classification of patients with disseminated cancer of the breast. Cancer 24:861-869, 1969
20. Pearlman NW, Jochimsen PR: Recurrent breast cancer: Factors influencing survival, including treatment. J Surg Oncol 11:21-29, 1979
21. Gisselbrecht C, Ganem C, Lepage E, et al: Cyclophosphamide (CTX), total body irradiation (TBI) + autologous bone marrow infusion (aBM) as consolidation for locally advanced and metastatic breast cancer (BC). Cancer Chemother Pharmacol 18:129, 1986 (suppl, abstr)
22. Peters WP, Shpall EJ, Jones RB, et al: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6:1368-1376, 1988
23. Dunphy FR, Spitzer G, Buzdar AU, et al: Treatment of estrogen-receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8:1-10, 1990
24. Kennedy MJ, Beveridge RA, Rowley SD, et al: High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83:920-926, 1991
25. Hortobagyi GN, Buzdar AU, Frye D, et al: Combined antiestrogen and cytotoxic therapy for metastatic breast cancer. Cancer 60:2596-2604, 1987
26. Johnson BE, Ihde DC, Bunn PA, et al: Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Ann Intern Med 103:430-438, 1985